A portfolio with profound benefits for patients and doctors
Our first focus is on ischaemic diseases and peripheral arterial diseases (PAD) such as critical limb ischaemia
Exosome-based therapies to treat serious diseases
Developing proprietary manufacturing technology and processes for high value exosome products
Working with global partners to take Australian innovation to the world
Our highly capable expert team has significant experience in the development and commercialisation of biological therapies
Ian Nisbet PhD
Email: ian.nisbet@vivazome.com
Tel: +61 (0)431 709 121
